These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36812902)

  • 41. Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized Trial.
    Teoh JY; Chan ES; Yip SY; Tam HM; Chiu PK; Yee CH; Wong HM; Chan CK; Hou SS; Ng CF
    Ann Surg Oncol; 2017 May; 24(5):1428-1434. PubMed ID: 27882470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour - a prospective multicentre observational study.
    Poletajew S; Krajewski W; Gajewska D; Sondka-Migdalska J; Borowik M; Buraczyński P; Dzięgała M; Łykowski M; Przudzik M; Tukiendorf A; Woźniak R; Bar K; Jabłonowski Z; Roslan M; Słojewski M; Zdrojowy R; Radziszewski P; Dziobek K
    Arch Med Sci; 2020; 16(4):863-870. PubMed ID: 32542089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
    Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Grading of complications of transurethral resection of bladder tumor using Clavien-Dindo classification system.
    Bansal A; Sankhwar S; Goel A; Kumar M; Purkait B; Aeron R
    Indian J Urol; 2016; 32(3):232-7. PubMed ID: 27555684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automated Extraction of Grade, Stage, and Quality Information From Transurethral Resection of Bladder Tumor Pathology Reports Using Natural Language Processing.
    Glaser AP; Jordan BJ; Cohen J; Desai A; Silberman P; Meeks JJ
    JCO Clin Cancer Inform; 2018 Dec; 2():1-8. PubMed ID: 30652586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
    Yuk HD; Kim JK; Jeong CW; Kwak C; Kim HH; Ku JH
    Biomed Res Int; 2018; 2018():9432606. PubMed ID: 30271788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intra- and postoperative complications classified according to the Clavien-Dindo classification in patients > 80 years after transurethral resection of the urinary bladder].
    Barakat B; Dawood Y; Horstmann M
    Aktuelle Urol; 2019 Jul; 50(3):274-279. PubMed ID: 29518819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis.
    Cui Y; Chen H; Liu L; Chen J; Qi L; Zu X
    J Laparoendosc Adv Surg Tech A; 2016 Mar; 26(3):196-202. PubMed ID: 26799841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
    Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
    World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
    Richards KA; Smith ND; Steinberg GD
    J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality Control Indicators for Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
    Akand M; Muilwijk T; Raskin Y; De Vrieze M; Joniau S; Van Der Aa F
    Clin Genitourin Cancer; 2019 Aug; 17(4):e784-e792. PubMed ID: 31097388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Aug; 38(8):684.e1-684.e8. PubMed ID: 32201059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?
    Chen CL; Liu CY; Cha TL; Hsu CY; Chou YC; Wu ST; Meng E; Sun GH; Yu DS; Tsao CW
    J Chin Med Assoc; 2015 Aug; 78(8):469-74. PubMed ID: 26074367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer.
    Yanagisawa T; Miki J; Yorozu T; Iwatani K; Obayashi K; Sato S; Kimura T; Takahashi H; Egawa S
    J Urol; 2021 Jun; 205(6):1622-1628. PubMed ID: 33502235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
    Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review.
    Schuettfort VM; Pradere B; Compérat E; Abufaraj M; Shariat SF
    Curr Opin Urol; 2021 Jul; 31(4):324-331. PubMed ID: 33973535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour.
    Suarez-Ibarrola R; Soria F; Abufaraj M; D'Andrea D; Preto M; Gust KM; Briganti A; Shariat SF; Gontero P
    BJU Int; 2019 Apr; 123(4):646-650. PubMed ID: 30248235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External validation and modification of nomogram for predicting positive resection margins before breast conserving surgery.
    Jung JJ; Kang E; Kim EK; Kim SM; Jang M; La Yun B; Park SY; Shin HC
    Breast Cancer Res Treat; 2020 Sep; 183(2):373-380. PubMed ID: 32647937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
    Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
    BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.